PHVS — PHARVARIS N V
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 131 SEC-registered investment managers reported holding PHVS (PHARVARIS N V) in their latest 13F filings, with a combined reported value of $2.46B across 71.43M shares. That is +6.5% by share count (+4.20M shares) versus the previous quarter, while reported value moved +30.6%. Ownership is concentrated: the five largest holders account for 36.9% of reported value and the top ten for 58.7%.
Compared with the prior quarter, 25 opened new positions, 47 added to existing stakes, 34 trimmed, 10 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of PHARVARIS N V (PHVS) include Fidelity Management & Research (FMR), Foresite Capital Management IV, LLC, venBio Partners LLC, ranked by reported 13F value among the 174 institutional holders on this page.
PHVS is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding PHVS
The superinvestors we track who report PHVS in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 3.65M | $126.33M | 0.37% | Hold |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 64 | 17.97M | $569.97M | -13.0% |
| Q2 2026 | 131 | 71.43M | $2.46B | +6.5% |
| Q1 2026 | 116 | 65.65M | $1.84B | -1.1% |
| Q4 2025 | 112 | 65.99M | $1.80B | +4.2% |
| Q3 2025 | 86 | 64.17M | $1.58B | +7.9% |
| Q2 2025 | 61 | 49.47M | $857.21M | -1.8% |
| Q1 2025 | 54 | 49.18M | $762.88M | +0.5% |
| Q4 2024 | 57 | 48.76M | $926.15M | +1.4% |
Over the 8 quarters shown, institutional share counts decreased 63% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+7.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.92M | $219.56M | 0.01% | Add | |
| 3.42M | $108.63M | 11.46% | Hold | |
| 1.65M | $52.39M | 2.15% | Reduce | |
| 987.64K | $31.33M | 5.32% | Add | |
| 966.72K | $30.66M | 0.00% | Add | |
| 808.64K | $25.65M | 4.09% | Add | |
| 412.83K | $13.09M | 0.00% | Add | |
| 409.52K | $12.99M | 0.01% | Add | |
| 372.55K | $11.82M | 5.14% | Add | |
| 349.07K | $11.07M | 0.01% | Add | |
| 282.87K | $8.97M | 0.02% | Add | |
| 187.57K | $5.95M | 0.03% | Reduce | |
| 151.41K | $4.80M | 0.00% | Reduce | |
| 150.00K | $4.76M | 0.22% | New | |
| 126.17K | $4.00M | 1.05% | Reduce | |
| 89.26K | $2.83M | 0.00% | Reduce | |
| 71.23K | $2.26M | 0.00% | Add | |
| 61.12K | $1.94M | 0.00% | Add | |
| 49.46K | $1.57M | 0.00% | Add | |
| 44.10K | $1.40M | 0.01% | New | |
| 43.13K | $1.37M | 0.00% | Reduce | |
| 41.52K | $1.32M | 0.00% | Add | |
| 40.30K | $1.28M | 0.00% | Add | |
| 38.13K | $1.21M | 0.01% | Reduce | |
| 29.85K | $946.75K | 0.56% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
Q2 2025 — 25 funds
New Positions (Q2 2026)
- TCG Crossover Management, LLC 1.01M sh · $34.86M
- DV EQUITIES, LLC 482.52K sh · $16.69M
- EcoR1 Capital, LLC 235.00K sh · $8.13M
- Walleye Capital LLC 200.42K sh · $6.93M
- Cinctive Capital Management LP 161.11K sh · $5.57M
- NEXTBio Capital Management LP 108.06K sh · $3.74M
- Lazard Asset Management 92.89K sh · $3.21M
- LAZARD ASSET MANAGEMENT LLC 92.89K sh · $3.21M
- GEODE CAPITAL MANAGEMENT, LLC 89.91K sh · $3.11M
- Moore Capital Management 44.00K sh · $1.52M
- Y-Intercept (Hong Kong) Ltd 39.93K sh · $1.38M
- VOYA INVESTMENT MANAGEMENT LLC 33.73K sh · $1.17M
Fully Exited (vs previous quarter)
- BAKER BROS. ADVISORS LP sold 375.00K sh · $10.59M
- STATE STREET CORP sold 152.94K sh · $4.32M
- SCHRODER INVESTMENT MANAGEMENT GROUP sold 158.02K sh · $4.31M
- DV Trading LLC sold 143.97K sh · $4.07M
- GREAT POINT PARTNERS LLC sold 82.80K sh · $2.34M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME sold 77.65K sh · $2.19M
- Logos Global Management LP sold 65.00K sh · $1.84M
- ALPS ADVISORS INC sold 52.15K sh · $1.47M
- Jump Financial, LLC sold 19.50K sh · $550.88K
- Quadrature Capital Ltd sold 13.72K sh · $387.68K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 6.92M | 6.57M | 6.28M | 6.40M | 6.40M | 5.42M | 5.40M | 5.40M | 5.21M | 5.21M | 5.19M | 5.19M | 3.21M | 3.39M | 3.32M | 3.32M | 3.32M | 3.32M | 3.32M | 3.30M |
| EQT Fund Management S.a r.l. | 3.42M | 3.42M | 3.42M | 3.42M | 3.42M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GENERAL ATLANTIC, L.P. | 1.65M | 6.55M | 8.03M | 8.03M | 8.03M | 7.53M | 7.53M | 7.53M | 7.53M | 7.53M | 7.53M | 6.16M | 4.41M | — | — | — | — | — | — | — |
| Jones Hill Capital LP | 987.64K | 677.88K | 167.01K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 966.72K | 771.45K | 757.21K | 708.56K | 414.42K | 201.09K | 192.87K | 194.19K | 195.35K | — | — | — | — | — | — | — | — | — | — | — |
| Patient Square Capital LP | 808.64K | 671.21K | 493.00K | 542.70K | 345.38K | 244.28K | 245.50K | 207.60K | 242.34K | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 412.83K | 97.34K | 164.32K | 248.33K | 58.26K | 59.77K | 75.36K | 27.00K | 24.25K | 23.30K | 29.04K | 22.49K | 33.70K | 45.33K | 48.98K | 38.18K | 19.09K | 16.82K | 16.18K | 18.26K |
| BNP Paribas Asset Management Holding S.A. | 409.52K | 4.56K | 5.72K | 5.51K | 3.26K | 3.26K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NEXTBio Capital Management LP | 372.55K | 108.06K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 349.07K | 254.79K | 71.94K | 137.73K | 130.75K | 3.74K | 7.45K | 1.04K | 1.59K | 167 | — | — | 50 | 1.30K | 422 | 2.80K | — | 799 | 728 | 423 |
| Qube Research & Technologies Ltd | 282.87K | 139.85K | 71.21K | 14.71K | — | — | — | — | — | — | 30.14K | 32.32K | 2.58K | — | — | — | — | — | — | — |
| Walleye Capital LLC | 187.57K | 200.42K | — | — | — | — | — | — | — | 48.77K | 97.18K | 77.87K | 81.02K | — | — | — | — | — | — | — |
| STATE STREET CORP | 151.41K | — | 152.94K | 161.50K | 142.78K | 93.67K | 93.78K | 92.01K | 53.98K | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 150.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HighVista Strategies LLC | 126.17K | 160.49K | 97.87K | 162.37K | — | 23.74K | 22.77K | 22.77K | 22.77K | 16.75K | 16.75K | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 89.26K | 89.91K | 89.13K | 86.80K | 78.54K | 54.10K | 38.33K | 38.33K | 36.98K | 31.22K | 31.22K | 21.59K | 21.59K | 18.64K | 18.64K | 18.64K | 18.64K | 18.64K | 18.64K | 18.64K |
| TD ASSET MANAGEMENT INC | 71.23K | 38.46K | 54.83K | 120.25K | 104.36K | 99.51K | 78.12K | 55.22K | 36.22K | 85.82K | 112.62K | — | — | — | — | — | — | — | — | — |
| Deutsche Bank AG | 61.12K | 53.47K | 53.72K | 56.39K | 51.80K | 28.19K | 28.17K | 18.17K | 16.08K | — | — | — | — | — | — | — | — | — | — | — |
| Swiss National Bank | 49.46K | 39.36K | 44.76K | 44.76K | 42.36K | 26.26K | 26.26K | 26.26K | 26.26K | — | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 44.10K | — | 19.50K | 26.30K | — | — | — | — | — | — | 11.70K | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PHVS?
As of 2026-Q2, 131 institutional funds reported holding PHVS (PHARVARIS N V) in SEC 13F filings, with a combined reported value of $2.46B.
How many shares of PHVS do institutions own?
13F filers reported 71.43M shares of PHVS, worth $2.46B in aggregate at the end of 2026-Q2.
Is institutional ownership of PHVS rising or falling?
Share counts moved +6.5% versus the prior quarter — accumulation.
Who are the top institutional holders of PHVS?
The largest 13F holders are Fidelity Management & Research (FMR), Foresite Capital Management IV, LLC, venBio Partners LLC, Viking Global Investors, VIKING GLOBAL INVESTORS LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of PHARVARIS N V?
The major shareholders of PHARVARIS N V (PHVS) by reported 13F value are Fidelity Management & Research (FMR), Foresite Capital Management IV, LLC, venBio Partners LLC, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 174 institutional holders.
Which legendary investors own PHVS?
1 of the legendary investors tracked on HoldingsHub report PHVS (PHARVARIS N V) in their latest 13F filings, led by Viking Global Investors. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on PHVS?
1 tracked superinvestors hold PHVS simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.